In yesterday’s Wall Street session, Singular Genomics Systems Inc (NASDAQ:OMIC) shares traded at $0.53, down -9.28% from the previous session.
As of this writing, 3 analysts cover Singular Genomics Systems Inc (NASDAQ:OMIC). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $1.00 and a low of $0.40, we find $0.70. Given the previous closing price of $0.58, this indicates a potential upside of 20.69 percent. OMIC stock price is now 34.13% away from the 50-day moving average and -48.20% away from the 200-day moving average. The market capitalization of the company currently stands at $38.48M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
There are 2 analysts who have given it a hold rating, whereas 1 have given it a buy rating. Brokers who have rated the stock have averaged $0.70 as their price target over the next twelve months.
With the price target reduced from $10 to $4.50, UBS Downgraded its rating from Buy to Neutral for Singular Genomics Systems Inc (NASDAQ: OMIC).
In other news, Kamdar Kim P., Director sold 200,000 shares of the company’s stock on Aug 15. The stock was sold for $106,960 at an average price of $0.53. Upon completion of the transaction, the Director now directly owns 3,763,985 shares in the company, valued at $1.99 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 14, Director Kamdar Kim P. sold 77,991 shares of the business’s stock. A total of $44,424 was realized by selling the stock at an average price of $0.57. This leaves the insider owning 3,963,985 shares of the company worth $2.1 million. Insiders disposed of 660,815 shares of company stock worth roughly $0.35 million over the past 1 year. A total of 44.59% of the company’s stock is owned by insiders.
During the past 12 months, Singular Genomics Systems Inc has had a low of $0.31 and a high of $3.00. As of last week, the company has a debt-to-equity ratio of 0.27, a current ratio of 16.18, and a quick ratio of 15.15. The fifty day moving average price for OMIC is $0.3924 and a two-hundred day moving average price translates $1.0158 for the stock.
The latest earnings results from Singular Genomics Systems Inc (NASDAQ: OMIC) was released for Jun, 2023. The net profit margin was -4411.72% and return on equity was -36.48% for OMIC.
Singular Genomics Systems Inc(OMIC) Company Profile
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.
